MedPath

Therapeutic effect of granulocyte colony-stimulating factor in patients with acute traumatic spinal cord injury

Phase 2
Conditions
Condition 1: Traumatic spinal cord injury. Condition 2: Traumatic spinal cord injury. Condition 3: Traumatic spinal cord injury. Condition 4: Traumatic spinal cord injury. Condition 5: Traumatic spinal cord injury.
Transport accidents
Other external causes of accidental injury
Other and unspecified injuries of thoracic spinal cord
Other and unspecified injuries of cervical spinal cord
Sequelae of injury of spinal cord
V01-V99
W00-X59
Registration Number
IRCT201504077369N2
Lead Sponsor
Vice Chancellor for Research and Technology of Guilan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
92
Inclusion Criteria

Acute traumatic spinal cord injury; Age between 18 to 65 years old
Exclusion criteria: Presence of intracranial lesions such as tumor, infection, ischemia or trauma; Past history of massive blood loss with transfusion; Past history of leukopenia or thrombocytopenia; Past history of hepatic or renal dysfunction; Past history of sever heart failure; Presence of splenomegaly or past history of it; Any evidence of malignancy during past 5 years; Pregnancy or lactation

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spinal cord injury grade. Timepoint: Before the intervention, 1 week after the intervention, 3 months after the intervention and 6 months after the intervention. Method of measurement: AIS grading system.;Sensory and motor function score. Timepoint: Before the intervention, 1 week after the intervention, 3 months after the intervention and 6 months after the intervention. Method of measurement: ASIA scoring system.
Secondary Outcome Measures
NameTimeMethod
-. Timepoint: -. Method of measurement: -.
© Copyright 2025. All Rights Reserved by MedPath